These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29443542)

  • 1. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of Lung Adenocarcinoma.
    Tian W; Li YS; Zhang JH; Li JJ; Gao JH
    DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
    Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
    Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.
    Tsou JA; Galler JS; Siegmund KD; Laird PW; Turla S; Cozen W; Hagen JA; Koss MN; Laird-Offringa IA
    Mol Cancer; 2007 Oct; 6():70. PubMed ID: 17967182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
    Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
    Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.
    Lenka G; Tsai MH; Lin HC; Hsiao JH; Lee YC; Lu TP; Lee JM; Hsu CP; Lai LC; Chuang EY
    Sci Rep; 2017 Feb; 7():42573. PubMed ID: 28198450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.
    He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q
    Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
    Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
    J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovol2 gene inhibits the Epithelial-to-Mesenchymal Transition in lung adenocarcinoma by transcriptionally repressing Twist1.
    Wang ZH; Li Z; Hu M; Yang QJ; Yan S; Wu RS; Li BA; Guo M
    Gene; 2017 Feb; 600():1-8. PubMed ID: 27884772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
    Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
    Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation-based diagnostic and prognostic biomarkers of nonsmoking lung adenocarcinoma patients.
    Zhang X; Gao C; Liu L; Zhou C; Liu C; Li J; Zhuang J; Sun C
    J Cell Biochem; 2019 Aug; 120(8):13520-13530. PubMed ID: 30920015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
    Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
    Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
    Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
    Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
    Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method.
    Cai Q; He B; Xie H; Zhang P; Peng X; Zhang Y; Zhao Z; Wang X
    Cancer Med; 2020 Oct; 9(20):7488-7502. PubMed ID: 32860318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
    Zhu XF; Zhu BS; Wu FM; Hu HB
    J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.